News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Adhesive Patch Biotech Zosano Pharma, Inc. Postpones $70 Million IPO


8/27/2014 6:53:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Zosano Pharma, a biotech developing a transdermal delivery system to treat osteoporosis, postponed its IPO. The Fremont, CA-based company originally planned to raise $70 million by offering 6.4 million shares at a price range of $10 to $12. At the midpoint of the proposed range, it would have commanded a fully diluted market value of $139 million. The IPO market has largely shut down in August, meaning Zosano could attempt to go public in September if the biotech window remains open.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq


comments powered by Disqus
Nasdaq
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES